| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |